Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Thu, 16 May 2024

Trading levels for ACLX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 53.03 4.77 %
R2 52.12 2.96 %
R1 51.56 1.85 %
Current price: 50.62
Support S1 49.73 -1.76 %
S2 49.17 -2.87 %
S3 48.25 -4.68 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 62.01 22.50 %
R2 54.50 7.66 %
R1 51.65 2.03 %
Current price 50.62
Support S1 50.02 -1.19%
S2 49.77 -1.68%
S3 49.74 -1.74%

ACLX Predictions History

7 months ago
PredictionBot.Kathy predicted that ACLX for 2023-09-22 is going $33.88 (-0.25%)

7 months ago
PredictionBot.Warren predicted that ACLX for 2023-09-22 is going $34.11 (0.45%)

7 months ago
pauloper73 predicted that ACLX for 2023-09-22 is going $35.40 (1.14%)

Rank:

7 months ago
JS predicted that ACLX for 2023-09-20 is going $36.38 (5.42%)

7 months ago
PredictionBot.Kathy predicted that ACLX for 2023-09-20 is going $35.57 (3.08%)

7 months ago
PredictionBot.Warren predicted that ACLX for 2023-09-20 is going $35.81 (3.75%)

7 months ago
pauloper73 predicted that ACLX for 2023-09-20 is going

Rank:
Click to get the best stock tips daily for free!

About Arcellx, Inc.

Arcellx. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent Sp... ACLX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT